1292620-71-3

Upstream product

• 1609356-23-1 methyl 2-chloro-4-(1,1-dioxidoisothiazolidin-2-yl)benzoate 
• 1609356-22-0 3-((3-chloro-4-(methoxycarbonyl)phenyl)amino)propane-1-sulfonic acid 

Downstream Products

• 1609355-43-2 C₂₄H₁₈Cl₂N₄O₃S 
• 1609355-71-6 C₁₈H₁₇Cl₂N₃O₄S 
• 1609355-72-7 C₂₂H₁₈Cl₂N₂O₄S 
• 1609355-42-1 C₂₆H₂₂ClN₃O₃S 
• 1609355-65-8 N-(3-benzamido-4-chlorophenyl)-2-chloro-4-(3,3-dioxido-1,3,4-oxathiazinan-4-yl)benzamide 
• 1609355-62-5 C₂₂H₁₇Cl₃N₂O₄S 
• 1609355-51-2 C₂₃H₁₈Cl₃N₃O₄S 
• 1609355-66-9 N-(2-chloro-5-(2-chloro-4-(1,1-dioxidoisothiazolidin-2-yl)benzamido)phenyl)nicotinamide 

Relevant academic research and scientific papers

A DUAL INHIBITOR OF WNT/BETA-CATENIN and SONIC HEDGEHOG SIGNAL TRANSDUCTION PATHWAYS

Disclosed herein, inter alia, are compositions and methods for modulating the Wnt pathway.

CYCLIC SULFONAMIDE CONTAINING DERIVATIVES AS INHIBITORS OF HEDGEHOG SIGNALING PATHWAY

The invention relates generally to the creation and use of cyclic sulfonamide containing derivatives to inhibit the hedgehog signaling pathway and to the use of those compounds for the treatment of hyperproliferative diseases and angiogenesis mediated diseases.